Search research articles
Contact Us
Filters
Showing results (11-20 of 46) with videos related to
Page
of 5
Sort By:
Cell Reports
|
December 26, 2019
Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site following Vaccination of Humans
Seth J Zost, Juhye Lee, Megan E Gumina, et al.
Elife
|
August 28, 2019
Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin
Juhye M Lee, Rachel Eguia, Seth J Zost, et al.
Frontiers in Microbiology
|
October 14, 2021
The Crossroads of Glycoscience, Infection, and Immunology
Tanya R McKitrick, Margaret E Ackerman, Robert M Anthony, et al.
Nature Communications
|
August 24, 2018
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
Norbert Pardi, Kaela Parkhouse, Ericka Kirkpatrick, et al.
Biorxiv : the Preprint Server for Biology
|
January 27, 2021
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
Naveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, et al.
Cell Reports. Medicine
|
November 7, 2023
SARS-CoV-2 antibodies from children exhibit broad neutralization and belong to adult public clonotypes
Steven C Wall, Naveenchandra Suryadevara, Changil Kim, et al.
Cell
|
October 29, 2021
Pan-ebolavirus protective therapy by two multifunctional human antibodies
Pavlo Gilchuk, Charles D Murin, Robert W Cross, et al.
Journal of Virology
|
November 6, 2025
Mouse-adapted SARS-CoV-2 Omicron BA.5 infection induces post-acute lung fibrosis in BALB/c mice
John M Powers, Sarah R Leist, Naveenchandra Suryadevara, et al.
Biorxiv : the Preprint Server for Biology
|
August 12, 2025
Mouse Adapted Omicron BA.5 Induces A Fibrotic Lung Disease Phenotype in BALB/c Mice
John M Powers, Sarah R Leist, Naveenchandra Suryadevara, et al.
Cell
|
March 27, 2021
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
Naveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 46) with videos related to
Sort By:
Page
of 5
Cell Reports
|
December 26, 2019
Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site following Vaccination of Humans
Seth J Zost, Juhye Lee, Megan E Gumina, et al.
Elife
|
August 28, 2019
Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin
Juhye M Lee, Rachel Eguia, Seth J Zost, et al.
Frontiers in Microbiology
|
October 14, 2021
The Crossroads of Glycoscience, Infection, and Immunology
Tanya R McKitrick, Margaret E Ackerman, Robert M Anthony, et al.
Nature Communications
|
August 24, 2018
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
Norbert Pardi, Kaela Parkhouse, Ericka Kirkpatrick, et al.
Biorxiv : the Preprint Server for Biology
|
January 27, 2021
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
Naveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, et al.
Cell Reports. Medicine
|
November 7, 2023
SARS-CoV-2 antibodies from children exhibit broad neutralization and belong to adult public clonotypes
Steven C Wall, Naveenchandra Suryadevara, Changil Kim, et al.
Cell
|
October 29, 2021
Pan-ebolavirus protective therapy by two multifunctional human antibodies
Pavlo Gilchuk, Charles D Murin, Robert W Cross, et al.
Journal of Virology
|
November 6, 2025
Mouse-adapted SARS-CoV-2 Omicron BA.5 infection induces post-acute lung fibrosis in BALB/c mice
John M Powers, Sarah R Leist, Naveenchandra Suryadevara, et al.
Biorxiv : the Preprint Server for Biology
|
August 12, 2025
Mouse Adapted Omicron BA.5 Induces A Fibrotic Lung Disease Phenotype in BALB/c Mice
John M Powers, Sarah R Leist, Naveenchandra Suryadevara, et al.
Cell
|
March 27, 2021
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
Naveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, et al.
Page
of 5